We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
-16.07%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$3.09B
AUM Growth
-$461M
Cap. Flow
+$404M
Cap. Flow %
13.07%
Top 10 Hldgs %
27.53%
Holding
139
New
26
Increased
37
Reduced
15
Closed
17

Top Buys

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$72.8M
2
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$58.7M
3
CRWD icon
CrowdStrike
CRWD
+$55.7M
4
DT icon
Dynatrace
DT
+$36.1M
5
DHI icon
D.R. Horton
DHI
+$33.2M

Top Sells

Rank Stock Value
1
MYOV
Myovant Sciences Ltd.
MYOV
+$37.3M
2
TTD icon
Trade Desk
TTD
+$32.3M
3
PANW icon
Palo Alto Networks
PANW
+$30.4M
4
IAA
IAA, Inc. Common Stock
IAA
+$28.7M
5
PAYC icon
Paycom
PAYC
+$26.5M

Sector Composition

Rank Sector Weight
1 Healthcare 44.32%
2 Technology 23.01%
3 Industrials 9.93%
4 Consumer Discretionary 5.91%
5 Utilities 4.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGEN
76
DELISTED
Seagen Inc. Common Stock
SGEN
$11.8M 0.38%
+102,500
New +$11.4M
MDB icon
77
MongoDB
MDB
$27.1B
$11.7M 0.38%
86,000
-6,500
-7% -$960K
PHAT icon
78
Phathom Pharmaceuticals
PHAT
$708M
$11.6M 0.38%
450,000
– –
RGEN icon
79
Repligen
RGEN
$7.96B
$11.5M 0.37%
119,000
– –
DNTH icon
80
Dianthus Therapeutics
DNTH
$5.84B
$11.2M 0.36%
111,853
-100,265
-47% -$18.6M
VRTX icon
81
Vertex Pharmaceuticals
VRTX
$121B
$10.8M 0.35%
+45,500
New +$10.4M
XPO icon
82
XPO
XPO
$23.5B
$10.7M 0.35%
636,107
– –
EIDX
83
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$10.4M 0.34%
+213,000
New +$10.9M
DCPH
84
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$10M 0.32%
+243,000
New +$13.5M
LKFT
85
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.78B
$9.99M 0.32%
51,000
– –
ARVN icon
86
Arvinas
ARVN
$518M
$9.27M 0.3%
+230,000
New +$10.8M
ARYAU
87
DELISTED
ARYA Sciences Acquisiton Corp. Unit
ARYAU
$9.03M 0.29%
800,000
– –
XNCR icon
88
Xencor
XNCR
$1.5B
$8.96M 0.29%
300,000
– –
ETNB
89
DELISTED
89bio
ETNB
$8.84M 0.29%
350,000
– –
MKC icon
90
McCormick & Company Non-Voting
MKC
$13.7B
$8.47M 0.27%
+120,000
New +$9.31M
EPIX
91
DELISTED
ESSA Pharma
EPIX
$7.64M 0.25%
2,010,169
– –
ALLK
92
DELISTED
Allakos
ALLK
$7.12M 0.23%
+160,000
New +$10.9M
MYOV
93
DELISTED
Myovant Sciences Ltd.
MYOV
$6.04M 0.2%
800,000
-3,326,131
-81% -$37.3M
EQIX icon
94
Equinix
EQIX
$101B
$4.37M 0.14%
7,000
+2,400
+52% +$1.44M
FENC icon
95
Fennec Pharmaceuticals
FENC
$332M
$4.28M 0.14%
720,000
– –
NEE icon
96
NextEra Energy
NEE
$181B
$4.19M 0.14%
69,600
+16,800
+32% +$1.06M
CMS icon
97
CMS Energy
CMS
$22.6B
$4.09M 0.13%
69,700
+22,700
+48% +$1.45M
AQN icon
98
Algonquin Power & Utilities
AQN
$4.49B
$3.82M 0.12%
+285,300
New +$4.16M
WEC icon
99
WEC Energy
WEC
$35.7B
$3.52M 0.11%
+39,900
New +$3.84M
JKHY icon
100
Jack Henry & Associates
JKHY
$10.9B
$3.45M 0.11%
+22,200
New +$3.45M
2 3
4
5 6

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q1 2020 Portfolio in Review

As of Q1 2020, Eventide Asset Management held 139 positions worth $3.09B, down 13% from $3.55B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Eventide Asset Management deployed $404M of net new capital in Q1 2020, opening 26 new positions and adding to 37 existing holdings. Its largest new stake was CrowdStrike: 3,948,000 shares worth $55M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 47% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Myovant Sciences Ltd., an estimated $37.3M trimmed.

  • Eventide Asset Management's largest Q1 2020 buy was CrowdStrike: 3,948,000 shares worth $55M.
  • Eventide Asset Management added most to Exact Sciences in Q1 2020, an estimated $72.8M increase.
  • Eventide Asset Management's biggest Q1 2020 reduction was Myovant Sciences Ltd., cutting an estimated $37.3M.
  • Eventide Asset Management fully exited IAA, Inc. Common Stock in Q1 2020, selling an estimated $28.7M.
  • Eventide Asset Management's ten largest holdings make up 28% of its $3.09B portfolio in Q1 2020.
  • Eventide Asset Management opened 26 new positions and closed 17 in Q1 2020.
  • Eventide Asset Management's portfolio value fell 13% quarter-over-quarter to $3.09B.

Based on Eventide Asset Management's 13F filing for Q1 2020, filed 15 May 2020.